Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Rating of "Buy" by Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has been given a consensus rating of "Buy" by the six research firms that are presently covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $8.63.

BIOX has been the topic of a number of research reports. Oppenheimer reduced their target price on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating on the stock in a report on Tuesday, April 22nd. Lake Street Capital dropped their target price on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a research report on Friday, February 7th. Finally, Canaccord Genuity Group decreased their target price on Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating for the company in a research report on Thursday, February 13th.

Bioceres Crop Solutions Stock Performance

Bioceres Crop Solutions stock traded down $0.04 during midday trading on Thursday, hitting $4.19. The company's stock had a trading volume of 11,440 shares, compared to its average volume of 167,274. Bioceres Crop Solutions has a 1-year low of $3.51 and a 1-year high of $13.18. The company has a 50-day moving average price of $4.38 and a two-hundred day moving average price of $5.79. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.33 and a quick ratio of 0.96. The company has a market cap of $262.76 million, a price-to-earnings ratio of 208.60 and a beta of 0.60.

Institutional Investors Weigh In On Bioceres Crop Solutions

Large investors have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. grew its position in shares of Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock worth $708,000 after purchasing an additional 29,693 shares in the last quarter. Stifel Financial Corp lifted its holdings in shares of Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock worth $321,000 after buying an additional 10,224 shares during the period. Ballast Asset Management LP raised its stake in Bioceres Crop Solutions by 23.5% in the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock worth $2,620,000 after buying an additional 82,187 shares in the last quarter. Fourth Sail Capital LP boosted its holdings in shares of Bioceres Crop Solutions by 16.6% in the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company's stock valued at $22,490,000 after buying an additional 527,859 shares in the last quarter. Finally, Long Focus Capital Management LLC boosted its holdings in Bioceres Crop Solutions by 130.7% in the fourth quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company's stock worth $4,528,000 after acquiring an additional 421,931 shares in the last quarter. Institutional investors own 17.68% of the company's stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.